Pacira BioSciences (PCRX) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
Pacira BioSciences insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 5 sold $2.8M of PCRX stock on the open market.
Get emailed when insiders cluster-buy stocks like PCRX
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
PCRX insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $218K | 1 |
| Q3 2026 | — | 0 | $71K | 1 |
| Q2 2026 | — | 0 | $1.0M | 6 |
| Q1 2026 | — | 0 | $473K | 5 |
| Q4 2025 | — | 0 | $989K | 4 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Pacira BioSciences, Inc. insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $2.8M. 16 of 17 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 9 NewSEC | Lauren RikerPresident | Sell Plan | 6,00062,284 held (−9%) | $36.32 | $218K | -0.0% | — |
| Aug 18SEC | Jonathan SloninChief Medical Officer | Sell Plan | 3,040216,384 held (−1%) | $23.23 | $71K | +56.3% | — |
| Jun 12SEC | Lauren RikerPresident | Sell Plan | 6,11562,284 held (−9%) | $23.50 | $144K | +54.5% | — |
| Jun 5SEC | Kristen WilliamsChief Administrative Officer | Sell Plan | 10,259167,062 held (−6%) | $22.27 | $228K | +63.0% | — |
| Apr 24SEC | Shawn CrossCFO | Sell Plan | 12,941105,341 held (−11%) | $25.16 | $326K | +44.3% | — |
| Apr 22SEC | Shawn CrossCFO | Sell Plan | 7,714105,341 held (−7%) | $25.14 | $194K | +44.4% | — |
| Apr 22SEC | Shawn CrossCFO | Sell Plan | 2,845105,341 held (−3%) | $25.01 | $71K | +45.2% | — |
| Apr 22SEC | Shawn CrossCFO | Sell Plan | 1,500105,341 held (−1%) | $25.01 | $38K | +45.2% | — |
| Mar 19SEC | Jonathan SloninChief Medical Officer | Sell Plan | 3,261223,640 held (−1%) | $22.82 | $74K | +59.1% | — |
| Mar 19SEC | Mark FroimsonDirector | Sell | 50020,136 held (−2%) | $21.81 | $11K | +66.5% | — |
| Feb 3SEC | Kristen WilliamsChief Administrative Officer | Sell Plan | 13,137131,303 held (−9%) | $20.53 | $270K | +76.9% | — |
| Feb 3SEC | Lauren RikerPresident | Sell Plan | 4,00052,313 held (−7%) | $20.81 | $83K | +74.5% | — |
| Jan 6SEC | Lauren RikerPresident | Sell Plan | 1,41659,064 held (−2%) | $24.24 | $34K | +49.8% | — |
| Dec 11SEC | Shawn CrossCFO | Sell Plan | 15,89656,250 held (−22%) | $25.03 | $398K | +45.1% | — |
| Dec 11SEC | Shawn CrossCFO | Sell Plan | 9,10456,250 held (−14%) | $25.14 | $229K | +44.4% | — |
| Nov 19SEC | Jonathan SloninChief Medical Officer | Sell Plan | 3,960178,367 held (−2%) | $24.09 | $95K | +50.7% | — |
| Nov 13SEC | Shawn CrossCFO | Sell Plan | 12,06056,250 held (−18%) | $22.09 | $266K | +64.4% | — |
Insiders at Pacira BioSciences, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Shawn CrossCFO | — | $1.5M | Apr 24, 2026 | — |
| Kristen WilliamsChief Administrative Officer | — | $498K | Jun 5, 2026 | — |
| Lauren RikerPresident | — | $479K | Oct 9, 2026 | — |
| Jonathan SloninChief Medical Officer | — | $240K | Aug 18, 2026 | — |
| Mark FroimsonDirector | — | $11K | Mar 19, 2026 | — |
PCRX stock: common questions
Are Pacira BioSciences, Inc. insiders buying PCRX stock?
In the past 12 months, 0 insiders reported open-market purchases of PCRX worth $0.
Are Pacira BioSciences, Inc. insiders selling PCRX stock?
5 insiders reported sales worth $2.8M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is PCRX's 52-week range?
Over the past year PCRX has traded between $19.16 and $36.39. It last closed at $36.31 on Oct 9, 2026.